Franco D, Smadja C, Kahwaji F, Grange D, Kemeny F, Traynor O
Recherche sur la Chirurgie du Foie et de l'Hypertension Portale, Hôpital Paul Brousse, Villejuif, France.
Arch Surg. 1988 Apr;123(4):519-22. doi: 10.1001/archsurg.1988.01400280133027.
Between 1982 and 1986, liver segmentectomies were performed in 19 patients with liver tumors, including ten hepatocellular carcinomas, six liver metastases, one cholangiocarcinoma, and two benign tumors. During surgery, patients received a mean (+/- 1 SD) of 1050 +/- 150 mL of packed red blood cells and 860 +/- 80 mL of fresh-frozen plasma. There were no operative deaths. The only complication was a prolonged leakage of ascites through the abdominal drain in one patient with cirrhosis. Seven patients with hepatocellular carcinoma were still alive at this writing, with a follow-up ranging from two months to four years. The four patients with metastases from colorectal carcinomas were alive after follow-up times ranging from six to 24 months. These results suggest that liver segmentectomy is a safe procedure and should be considered as the operation of choice for resection of limited liver tumors.
1982年至1986年间，对19例肝脏肿瘤患者实施了肝段切除术，其中包括10例肝细胞癌、6例肝转移瘤、1例胆管癌和2例良性肿瘤。手术期间，患者平均（±1标准差）接受了1050±150毫升浓缩红细胞和860±80毫升新鲜冰冻血浆。无手术死亡病例。唯一的并发症是1例肝硬化患者通过腹腔引流管出现腹水长期渗漏。撰写本文时，7例肝细胞癌患者仍存活，随访时间为2个月至4年。4例结直肠癌肝转移患者在随访6至24个月后仍存活。这些结果表明，肝段切除术是一种安全的手术方式，对于局限性肝脏肿瘤的切除应被视为首选手术。
